Rheumatology Highlights Report
Cardiovascular Aspects
of Rheumatic Disease
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: July 20, 2009
Expiration Date: July 20, 2010
Estimated Time of Completion: 15 minutes
Description
The Rheumatology Highlights Report is designed for the busy clinician. This series highlights key scientific presentations and/or abstracts from international and national rheumatology meetings. Clinical experts attend these meetings and select the most significant data to report. Each activity includes a 15-minute presentation with supporting materials and commentary on clinical implications.
Objectives
After completing this activity, the participant will be able to do the following:
- Explain the epidemiology of cardiovascular disease and mortality in patients with rheumatoid arthritis and systemic lupus erythematosus.
- Review recent advances in the predictors of cardiovascular risk in patients with rheumatoid arthritis.
- Discuss the European League against Rheumatism recommendations on cardiovascular risk management in patients with rheumatoid arthritis and other types of inflammatory arthritis.
Target Audience
Rheumatologists are the primary audience for these activities, as well as other health care professionals managing patients with rheumatic disease, including primary care practitioners, internists, and cardiologists.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman, Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic & Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Faculty
Ernest Choy, MD
Sir Alfred Baring Garrod Clinical Trials Unit
Academic Department of Rheumatology
King’s College London
London, England
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty member has indicated that he may have a relationship, which in the context of his presentation, could be perceived as a potential conflict of interest:
| Leonard H. Calabrese, DO | ||
| Consulting, Teaching & Speaking | Abbott; Amgen; Centocor; Genentech; Wyeth | |
| Consulting | Elan; Roche | |
The following faculty member has indicated he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
Ernest Choy, MD
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants
for partial support of this activity from:
Amgen and Wyeth Pharmaceuticals
Centocor Ortho Biotech
Genentech and Biogen Idec
This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education, the RJ Fasenmyer Center for Clinical Immunology and UNITECH Communications®.
